Patents Assigned to VIRONGY L.L.C.
  • COMPOSITIONS AND METHODS FOR USING COMBINATIONS OF ACTIN-BASED PEPTIDES TO MODULATE CELLULAR BIOACTIVITY
    Publication number: 20240108687
    Abstract: The present disclosure relates to combinations and formulations of actin-based peptides with molecules to enhance the bioactivities of actin-based peptides for enhancing their abilities for modulating actin-related cellular bioactivity and cellular susceptibility to viral infection.
    Type: Application
    Filed: February 14, 2022
    Publication date: April 4, 2024
    Applicant: Virongy L.L.C.
    Inventor: Yuntao WU
  • Retro- and lenti-HBV hybrid vectors and constructs
    Patent number: 10793876
    Abstract: The present disclosure relates to the design of a retro- or lenti-viral HBV (hepatitis B virus) hybrid vector for delivery of HBV genomes into cells such as liver cells. Provided herein are design, methodology, compositions, and the like for such vectors for delivering HBV genes or genomes into cells for anti-HBV drug screening, HBV research, or test of anti-HBV therapeutics.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: October 6, 2020
    Assignee: VIRONGY L.L.C.
    Inventor: Yuntao Wu